Published in Psychopharmacology (Berl) on November 01, 2002
Putting brain training to the test. Nature (2010) 3.88
The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci (2009) 3.79
The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl) (2008) 2.07
Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev (2009) 1.74
Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol (2010) 1.71
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther (2009) 1.67
Cognitive mechanisms of treatment in depression. Neuropsychopharmacology (2011) 1.43
Modafinil enhances thalamocortical activity by increasing neuronal electrotonic coupling. Proc Natl Acad Sci U S A (2007) 1.43
Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl) (2007) 1.42
Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl) (2005) 1.39
The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol (2011) 1.39
Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Med (2013) 1.31
Extended practice and aerobic exercise interventions benefit untrained cognitive outcomes in older adults: a meta-analysis. J Am Geriatr Soc (2011) 1.29
Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. Psychopharmacology (Berl) (2004) 1.22
Dopamine transporter-related effects of modafinil in rhesus monkeys. Psychopharmacology (Berl) (2010) 1.22
Modafinil and memory: effects of modafinil on Morris water maze learning and Pavlovian fear conditioning. Behav Neurosci (2009) 1.21
Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. Neuropsychopharmacology (2011) 1.18
When is diminishment a form of enhancement? Rethinking the enhancement debate in biomedical ethics. Front Syst Neurosci (2014) 1.14
Psychostimulants and cognition: a continuum of behavioral and cognitive activation. Pharmacol Rev (2013) 1.13
R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. Biol Psychiatry (2012) 1.12
To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students. PLoS One (2013) 1.11
Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug Alcohol Depend (2009) 1.11
Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology (2010) 1.10
Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study. Psychopharmacology (Berl) (2010) 1.07
Effects of modafinil on working memory processes in humans. Psychopharmacology (Berl) (2004) 1.05
AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology (2012) 1.04
Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther (2012) 1.04
Moral Enhancement. J Appl Philos (2008) 1.04
Developing treatments for cognitive deficits in schizophrenia: the challenge of translation. J Psychopharmacol (2014) 1.04
Acute effects of modafinil on brain resting state networks in young healthy subjects. PLoS One (2013) 1.02
Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) (2004) 1.02
The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology (Berl) (2013) 1.02
Modafinil effects in multiple sclerosis patients with fatigue. J Neurol (2009) 1.01
The likelihood of cognitive enhancement. Pharmacol Biochem Behav (2011) 1.00
Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav (2011) 1.00
Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate. Front Syst Neurosci (2014) 1.00
Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review. Addiction (2014) 0.99
Memory and psychostimulants: modulation of Pavlovian fear conditioning by amphetamine in C57BL/6 mice. Psychopharmacology (Berl) (2008) 0.99
A placebo-controlled trial of modafinil for nicotine dependence. Drug Alcohol Depend (2008) 0.98
Modafinil modulation of the default mode network. Psychopharmacology (Berl) (2010) 0.96
Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers. Psychopharmacology (Berl) (2005) 0.95
Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. Sleep (2009) 0.95
Lack of effects of guanfacine on executive and memory functions in healthy male volunteers. Psychopharmacology (Berl) (2005) 0.94
Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain. Front Syst Neurosci (2014) 0.94
Dopamine receptor mediation of the exploratory/hyperactivity effects of modafinil. Neuropsychopharmacology (2011) 0.94
The promise and predicament of cosmetic neurology. J Med Ethics (2006) 0.93
The orexins/hypocretins and schizophrenia. Schizophr Bull (2007) 0.93
Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment. Am J Addict (2010) 0.92
Mechanisms of modafinil: A review of current research. Neuropsychiatr Dis Treat (2007) 0.92
Modulatory effects of modafinil on neural circuits regulating emotion and cognition. Neuropsychopharmacology (2010) 0.92
Modafinil improves rapid shifts of attention. Psychopharmacology (Berl) (2008) 0.92
Modafinil in the media: metaphors, medicalisation and the body. Soc Sci Med (2008) 0.91
Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology (2012) 0.90
Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Psychopharmacology (Berl) (2003) 0.90
'Positive biology' as a new paradigm for the medical sciences. Focusing on people who live long, happy, healthy lives might hold the key to improving human well-being. EMBO Rep (2012) 0.90
Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes. Br J Clin Pharmacol (2013) 0.88
Stress modulation of the memory retrograde-enhancing effects of the awakening drug modafinil in mice. Psychopharmacology (Berl) (2007) 0.87
Mechanism based approaches for rescuing and enhancing cognition. Front Neurosci (2013) 0.87
Recent advances in treating cognitive impairment in schizophrenia. Psychopharmacology (Berl) (2008) 0.87
Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study. Drug Alcohol Depend (2014) 0.86
The ethics of elective psychopharmacology. Int J Neuropsychopharmacol (2011) 0.85
Response inhibition and interference control in obsessive-compulsive spectrum disorders. Front Hum Neurosci (2014) 0.85
Amphetamine and extinction of cued fear. Neurosci Lett (2009) 0.84
The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people. Philos Trans R Soc Lond B Biol Sci (2015) 0.83
Interactions between modafinil and cocaine during the induction of conditioned place preference and locomotor sensitization in mice: implications for addiction. Behav Brain Res (2012) 0.82
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs. NeuroRx (2006) 0.82
Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors. J Natl Cancer Inst (2014) 0.82
Moral and social reasons to acknowledge the use of cognitive enhancers in competitive-selective contexts. BMC Med Ethics (2016) 0.82
Effects of modafinil on cognitive functions in first episode psychosis. Psychopharmacology (Berl) (2011) 0.82
The effects of methylphenidate on cerebral activations to salient stimuli in healthy adults. Exp Clin Psychopharmacol (2013) 0.82
Sleep Deprivation Impairs and Caffeine Enhances My Performance, but Not Always Our Performance. Pers Soc Psychol Rev (2016) 0.82
Effects of non-pharmacological or pharmacological interventions on cognition and brain plasticity of aging individuals. Front Syst Neurosci (2014) 0.82
Behavioral effects of modafinil in marmoset monkeys. Psychopharmacology (Berl) (2006) 0.82
Modulation of fronto-cortical activity by modafinil: a functional imaging and fos study in the rat. Neuropsychopharmacology (2011) 0.82
Modafinil restores methamphetamine induced object-in-place memory deficits in rats independent of glutamate N-methyl-D-aspartate receptor expression. Drug Alcohol Depend (2013) 0.81
Fronto-striatal circuits in response-inhibition: Relevance to addiction. Brain Res (2014) 0.80
Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. J Stud Alcohol Drugs (2011) 0.80
A review of the effects of modafinil on cognition in schizophrenia. Schizophr Bull (2007) 0.80
Early markers of cognitive enhancement: developing an implicit measure of cognitive performance. Psychopharmacology (Berl) (2013) 0.79
Translational Aspects of the Novel Object Recognition Task in Rats Abstinent Following Sub-Chronic Treatment with Phencyclidine (PCP): Effects of Modafinil and Relevance to Cognitive Deficits in Schizophrenia. Front Psychiatry (2010) 0.79
Modafinil alters intrinsic functional connectivity of the right posterior insula: a pharmacological resting state fMRI study. PLoS One (2014) 0.79
Therapeutic options and challenges for substances of abuse. Dialogues Clin Neurosci (2007) 0.79
Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison. Psychopharmacology (Berl) (2007) 0.78
Wake-promoting agent modafinil worsened attentional performance following REM sleep deprivation in a young-adult rat model of 5-choice serial reaction time task. Psychopharmacology (Berl) (2010) 0.78
The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans. Pharmacol Biochem Behav (2010) 0.78
Effects of acute modafinil on cognition in trichotillomania. Psychopharmacology (Berl) (2010) 0.77
Haplotype polymorphism in the alpha-2B-adrenergic receptor gene influences response inhibition in a large Chinese sample. Neuropsychopharmacology (2012) 0.77
Hemodynamic profiles and tolerability of modafinil in the treatment of postural tachycardia syndrome: a randomized, placebo-controlled trial. J Clin Psychopharmacol (2014) 0.76
The effects of modafinil on mood and cognition in Huntington's disease. Psychopharmacology (Berl) (2008) 0.76
Methylphenidate alters selective attention by amplifying salience. Psychopharmacology (Berl) (2015) 0.76
"Messing with the mind": evolutionary challenges to human brain augmentation. Front Syst Neurosci (2014) 0.76
Why is Cognitive Enhancement Deemed Unacceptable? The Role of Fairness, Deservingness, and Hollow Achievements. Front Psychol (2016) 0.76
Modafinil Improves Episodic Memory and Working Memory Cognition in Patients With Remitted Depression: A Double-Blind, Randomized, Placebo-Controlled Study. Biol Psychiatry Cogn Neurosci Neuroimaging (2017) 0.75
The real-time fMRI neurofeedback based stratification of Default Network Regulation Neuroimaging data repository. Neuroimage (2016) 0.75
Modafinil increases the latency of response in the Hayling Sentence Completion Test in healthy volunteers: a randomised controlled trial. PLoS One (2014) 0.75
Ready for takeoff? A critical review of armodafinil and modafinil for the treatment of sleepiness associated with jet lag. Nat Sci Sleep (2010) 0.75
Probable Nootropicinduced Psychiatric Adverse Effects: A Series of Four Cases. Innov Clin Neurosci (2016) 0.75
Modafinil in sports: ethical considerations. Br J Sports Med (2005) 0.75
Evaluation of the Effect of Modafinil on Cognitive Functions in Patients with Idiopathic Hypersomnia with P300. Med Sci Monit (2015) 0.75
Stimulant drug effects on touchscreen automated paired-associates learning (PAL) in rats. Learn Mem (2016) 0.75
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci (2005) 16.18
Inhibition and the right inferior frontal cortex. Trends Cogn Sci (2004) 9.78
Grand challenges in global mental health. Nature (2011) 8.40
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci (2003) 5.94
Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci (2004) 5.55
Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev (2008) 4.97
Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci (2008) 4.85
High impulsivity predicts the switch to compulsive cocaine-taking. Science (2008) 4.76
Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev (2004) 4.38
Cognition in schizophrenia: summary Nice Consultation Meeting 2012. Eur Neuropsychopharmacol (2013) 3.99
Impulsivity, compulsivity, and top-down cognitive control. Neuron (2011) 3.96
The mental wealth of nations. Nature (2008) 3.60
Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev (2007) 3.51
Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J Neurosci (2002) 3.50
Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. J Neurosci (2004) 3.48
Decision-making processes following damage to the prefrontal cortex. Brain (2002) 3.07
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain (2009) 3.03
Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev (2006) 2.96
Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci (2007) 2.95
Abnormal brain structure implicated in stimulant drug addiction. Science (2012) 2.85
Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol (2013) 2.85
The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain (2003) 2.81
Appetitive behavior: impact of amygdala-dependent mechanisms of emotional learning. Ann N Y Acad Sci (2003) 2.70
Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend (2005) 2.67
Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction. Behav Brain Res (2008) 2.61
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology (2009) 2.60
L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia (2003) 2.55
Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nat Neurosci (2004) 2.52
Serotonin modulates behavioral reactions to unfairness. Science (2008) 2.49
Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J Neurosci (2002) 2.49
Serotonin selectively influences moral judgment and behavior through effects on harm aversion. Proc Natl Acad Sci U S A (2010) 2.47
Neurochemical modulation of response inhibition and probabilistic learning in humans. Science (2006) 2.41
The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry (2002) 2.35
Intracranial EEG reveals a time- and frequency-specific role for the right inferior frontal gyrus and primary motor cortex in stopping initiated responses. J Neurosci (2009) 2.25
Limbic corticostriatal systems and delayed reinforcement. Ann N Y Acad Sci (2004) 2.24
Automatic independent component labeling for artifact removal in fMRI. Neuroimage (2007) 2.24
Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. Am J Psychiatry (2011) 2.24
Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci (2003) 2.22
Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology (2009) 2.21
Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science (2008) 2.20
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry (2013) 2.20
Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav (2007) 2.19
The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat Protoc (2008) 2.17
Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol Psychiatry (2010) 2.13
Risk taking during decision-making in normal volunteers changes with age. J Int Neuropsychol Soc (2004) 2.12
A componential analysis of task-switching deficits associated with lesions of left and right frontal cortex. Brain (2004) 2.11
Reflection impulsivity in current and former substance users. Biol Psychiatry (2006) 2.09
The natural history of treated Parkinson's disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry (2011) 2.08
Rates of problematic gambling in a British homeless sample: a preliminary study. J Gambl Stud (2015) 2.07
The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl) (2008) 2.07
Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. Am J Psychiatry (2012) 2.05
Decision-making in the adolescent brain. Nat Neurosci (2012) 2.05
Reconciling the role of serotonin in behavioral inhibition and aversion: acute tryptophan depletion abolishes punishment-induced inhibition in humans. J Neurosci (2009) 2.04
Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology (2004) 2.03
Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain (2011) 2.00
Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology (2003) 1.99
Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci (2012) 1.98
Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. Cereb Cortex (2007) 1.95
Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens. Proc Natl Acad Sci U S A (2005) 1.94
Neurocognitive mechanisms in depression: implications for treatment. Annu Rev Neurosci (2009) 1.92
Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry (2006) 1.92
The neuropsychiatry of impulsivity. Curr Opin Psychiatry (2007) 1.90
Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry (2008) 1.89
Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2003) 1.89
Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology (2005) 1.89
From the ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci Biobehav Rev (2013) 1.88
Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. J Neurosci (2008) 1.88
Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol (2010) 1.85
Theta burst stimulation dissociates attention and action updating in human inferior frontal cortex. Proc Natl Acad Sci U S A (2010) 1.84
Common neural substrates for inhibition of spoken and manual responses. Cereb Cortex (2008) 1.83
Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry (2007) 1.82
Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain (2007) 1.81
Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology (2006) 1.81
Lifting the veil on trichotillomania. Am J Psychiatry (2007) 1.81
Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology (2007) 1.81